Format

Send to

Choose Destination
Surg Oncol Clin N Am. 1999 Oct;8(4):703-23, vii.

Screening for gynecologic malignancies: A continuing responsibility.

Author information

1
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women's Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461, USA.

Abstract

Screening for cervical cancer with the Papanicolaou cervical smear has resulted in a decline in incidence and mortality from cervical cancer. Targeting the unscreened population is the next challenge to reduce the incidence of this disease further. Currently, there are no available screening modalities for endometrial or ovarian cancer. Breakthroughs in molecular genetics may result in screening tests for ovarian cancer.

PMID:
10452936
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center